Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors

References

• Young , JC , Moarefi , I and Hartl , FU . 2001 . Hsp90: A specialized but essential protein-folding tool . J. Cell. Biol. , 154 : 267 – 273 .
   PubMed Web of Science ®Google Scholar
• Chen , B , Zhong , D and Monteiro , D . 2006 . Comparative genomics and evolution of the Hsp90 family of genes across all kingdoms of organisms . BMC Genomics , 156 : 2164 – 2167 .
   Google Scholar
• Crevel , G , Bates , H , Huikeshoven , H and Cotterill , S . 2001 . The Drosophila Dpit47 protein is a nuclear Hsp90 co-chaperone that interacts with DNA polymerase alpha . J. Cell. Sci. , 114 : 2015 – 2025 .
   PubMed Web of Science ®Google Scholar
• Ferrarini , M , Heeltaps , S and Sochi , MR . 1992 . Unusual expression and localization of heat-shock proteins in human tumor cells . Int. J. Cancer , 51 : 613 – 619 .
   PubMed Web of Science ®Google Scholar
• Sharp , S and Workman , P . 2006 . Inhibitors of the HSP90 molecular chaperone: Current status . Adv. Cancer Res. , 95 : 323 – 348 .
   PubMed Web of Science ®Google Scholar
• Neckers , L and Ivy , SP . 2003 . Heat shock protein 90 . Curr. Opin. Oncol. , 15 : 419 – 424 .
   PubMed Web of Science ®Google Scholar
• Calderwood , SK , Khaleque , MA , Sawyer , DB and Ciocca , DR . 2006 . Heat shock proteins in cancer: Chaperones of tumorigenesis . Trends Biochem. Sci. , 31 : 164 – 172 .
   PubMed Web of Science ®Google Scholar
• Chiosis , G , Vilenchik , M , Kim , J and Solit , D . 2004 . Hsp90: The vulnerable chaperone . Drug Discov. Today , 9 : 881 – 888 .
   PubMed Web of Science ®Google Scholar
• Prodromou , C and Pearl , LH . 2003 . Structure and functional relationships of Hsp90 . Curr. Cancer Drug Target. , 5 : 301 – 323 .
   Web of Science ®Google Scholar
• Pearl , LH and Prodromou , C . 2001 . Structure, function, and mechanism of the Hsp90 molecular chaperone . Adv. Protein Chem. , 59 : 157 – 186 .
   PubMedGoogle Scholar
• Goetz , MP , Toft , DO , Ames , MM and Erlichman , C . 2003 . The Hsp90 chaperone complex as a novel target for cancer therapy . Ann. Oncol. , 8 : 1169 – 1176 .
   Web of Science ®Google Scholar
• Pearl , LH and Prodromou , C . 2000 . Structure and in vivo function of Hsp90 . Curr. Opin. Struct. Biol. , 1 : 46 – 51 .
   Web of Science ®Google Scholar
• Chiosis , G , Vilenchik , M , Kim , J and Solit , D . 2004 . Hsp90: The vulnerable chaperone . Drug Discov. Today , 9 : 881 – 888 .
   PubMed Web of Science ®Google Scholar
• Janin , YL . 2005 . Heat shock protein 90 inhibitors . J. Med. Chem. , 48 : 7503 – 7512 .
   PubMed Web of Science ®Google Scholar
• Fujiwara , H , Yamakuni , T , Ueno , M , Ishizuka , M , Shinkawa , T , Isobe , T and Ohizumi , Y . 2004 . IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in 1210 cells . J. Pharmacol. Exp. Ther. , 310 : 1288 – 1295 .
   PubMed Web of Science ®Google Scholar
• Zhang , L , Fan , J , Vu , K , Hong , K , Brazidec , JYL , Shi , J , Biamonte , M , Busch , DJ , Lough , RE , Grecko , R , Ran , Y , Sensintaffar , JL , Kamal , A , Lundgren , K , Francis , J , Burrows , RM , Timony , GA , Ulm , EH , Kasibhatla , SR and Boehm , MF . 2006 . 7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors . J. Med. Chem. , 49 : 5352 – 362 .
   PubMed Web of Science ®Google Scholar
• Dymock , B , Barril , X , Beswick , M , Collier , A , Davies , N , Drysdale , M , Fink , A , Fromont , C , Hubbard , RE , Massey , A , Surgenor , A and Wright , L . 2004 . Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures . Bioorg. Med. Chem. Lett. , 14 : 325 – 328 .
   PubMed Web of Science ®Google Scholar
• Gary , ELB , Matthew , DS , Prisinzano , TE and Brian , SJB . 2008 . Gedunin, a novel Hsp90 inhibitor: Semisynthesis of derivatives and preliminary structure-activity relationships . J. Med. Chem. , 51 : 6495 – 6502 .
   PubMed Web of Science ®Google Scholar
• Saxena , AK , Saxena , S and Chaudhaery , SS . 2010 . Molecular modeling and docking studies on Hsp90 inhibitors . SAR QSAR Environ. Res. , 21 : 1 – 20 .
   PubMed Web of Science ®Google Scholar
• Sakkiah , S , Thangapandian , S , John , S , Kwon , YJ and Lee , KW . 2010 . 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential Hsp90 inhibitors . Eur. J. Med. Chem. , 45 : 2132 – 2140 .
   PubMed Web of Science ®Google Scholar
• Kasibhatla , SR , Hong , K , Biamonte , MA , Busch , DJ , Karjian , PL , John , L , Sensintaffar , AK , Lough , RE , Brekken , J , Lundgren , K , Grecko , R , Gregg , A , Timony , YR , Mansfield , R , Fritz , LC , Ulm , E , Burrows , FJ and Boehm , MF . 2007 . Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity . J. Med. Chem. , 50 : 2767 – 2778 .
   PubMed Web of Science ®Google Scholar
• Catalyst, Version 4.7. Accelrys Inc., 2002
   Google Scholar
• Gold, Version 3.2, Cambridge Crystallographic Data Centre, Cambridge, UK
   Google Scholar
• Liu , F , You , QD and Chen , YD . 2007 . Pharmacophore identification of KSP inhibitors . Bioorg. Med. Chem. Lett. , 17 : 722 – 726 .
   PubMed Web of Science ®Google Scholar
• Equbal , T , Silakari , O , Rambabub , G and Ravikumar , M . 2007 . Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors . Bioorg. Med. Chem. Lett. , 17 : 1594 – 1600 .
   PubMed Web of Science ®Google Scholar
• Brooks , BR , Brucolleri , RE , Olafson , BD , States , DJ , Swaminathan , S and Karplus , M . 1983 . CHARMm: a program for macromolecular energy minimization and dynamics calculation . J. Comput. Chem. , 4 : 187 – 217 .
   Web of Science ®Google Scholar
• Hirashima , A , Eiraku , T , Kuwano , E , Taniguchi , E and Eto , M . 2002 . Three-dimensional pharmacophore hypotheses of octopamine receptor responsible for the inhibition of sex–pheromone production in plodia interpunctella . Internet Electron. J. Mol. Des. , 1 : 37 – 51 .
   Google Scholar
• Li , MY , Tsaib , KC and Xia , L . 2005 . Pharmacophore identification of a1A-adrenoceptor antagonists . Bioorg. Med. Chem. Lett. , 15 : 657 – 664 .
   PubMed Web of Science ®Google Scholar
• Verdonk , ML , Chessari , G , Cole , JC , Hartshorn , MJ , Murray , CW , Nissink , JW and Taylor , RD . 2005 . Modulating water molecules in protein-ligand docking using gold . J. Med. Chem. , 48 : 6504 – 6515 .
   PubMed Web of Science ®Google Scholar
• BCG Estimate: a Revolution in R&D, The Impact of Genomics (2001). Available at http://www.bcg.com/documents/file13745.pdf
   Google Scholar
• Lyne , PD . 2002 . Structure-based virtual screening: An overview . Drug Discov. Today , 7 : 1047 – 1055 .
   PubMed Web of Science ®Google Scholar
• Bharatham , N , Bharatham , K and Lee , KW . 2007 . P56 LCK Inhibitor Identification by Pharmacophore Modelling and Molecular Docking . Bull. Korean Chem. Soc. , 2 : 200 – 206 .
   Google Scholar